Aytu BioScience和Neos Therapeutics宣布与拟议合并相关的股东特别会议将于2021年3月18日举行查看全文
Linktu2021-02-09 19:41
$Neos治疗(NEOS)$ 纳斯达克:AYTU)股东所持每股Neos Therapeutics股票将获得0.1088股Aytu BioScience普通股。这项交易的价值约为4490万美元,预计将于2021年第二季度完成。查看全文
$Neos治疗(NEOS)$ 15-12B Securities registration termination [Section 12(b)] Accession Number: 0001213900-21-018394 Act: 34 Size: 12 KB 网页链接
$Neos治疗(NEOS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001123 Act: 33 Size: 1 KB 网页链接
$Neos治疗(NEOS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001122 Act: 33 Size: 1 KB 网页链接
$Neos治疗(NEOS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001121 Act: 33 Size: 1 KB 网页链接
$Neos治疗(NEOS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001120 Act: 33 Size: 1 KB 网页链接
$Neos治疗(NEOS)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-21-016771 Act: 34 Size: 816 KB 网页链接
$Neos治疗(NEOS)$ 8-K Current report, items 1.01, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.07, and 9.01 Accession Number: 0001213900-21-016770 Act: 34 Size: 817 KB 网页链接
$Neos治疗(NEOS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-039264 Size: 11 KB 网页链接
$Neos治疗(NEOS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-039226 Size: 18 KB 网页链接
$Neos治疗(NEOS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-039228 Size: 18 KB 网页链接